Skip to content
JOIN 7INVESTING TODAY – YOUR PORTFOLIO WILL THANK YOU!
LOGIN
Toggle Navigation
My Account
Advisor Updates
View All
Best Buys
Community Ideas
Strong Buys
Subscriber Calls
Watchlist
Company Updates
View All
Deep Dives
Recommendations
Articles
Portfolios
MENU
My Account
Advisor Updates
View All
Best Buys
Community Ideas
Strong Buys
Subscriber Calls
Watchlist
Company Updates
View All
Deep Dives
Recommendations
Articles
Portfolios
LOGIN
SUBSCRIBE TODAY
Search for:
FILTER CONTENT
Filtered (27)
Filters
Reset all
×
Biotechnology
×
After
Before
Retail
(
10
)
Enterprise Software
(
15
)
Consumer Discretionary
(
17
)
Consumer Staples
(
4
)
Internet Infrastructure
(
7
)
Semiconductors
(
6
)
Industrial
(
1
)
Pharmaceuticals
(
10
)
Biotechnology
(
27
)
Media
(
2
)
Energy
(
5
)
Financial Services
(
30
)
Banking
(
1
)
Commodities
(
1
)
Consumer Electronics
(
4
)
Entertainment
(
9
)
Health Care Technology
(
10
)
Insurance
(
2
)
Transportation
(
2
)
Travel
(
1
)
Space Economy
(
1
)
Cannabis
(
2
)
Real Estate
(
2
)
General
(
25
)
×
Show
(
27
)
Cancel
Research
By
Dana Abramovitz
Published On: January 17, 2023
That’s a Wrap for JPM23, What did We Learn?
READ MORE
By
Dana Abramovitz
Published On: January 10, 2023
JPM is Underway, Investor Updates and Deal-Making Galore!
READ MORE
By
Dana Abramovitz
Published On: October 30, 2022
Overcoming Some of the Complexities of Investing in Biotech
READ MORE
By
Simon Erickson
Published On: October 14, 2022
Why Simon Chose His Top Stock for October
READ MORE
By
Maxx Chatsko
Published On: January 26, 2022
“Very High Risk” Isn’t Very Helpful
READ MORE
By
Dana Abramovitz
Published On: January 19, 2022
The Complexities of Cancer: Part 2 of 3
READ MORE
By
Dana Abramovitz
Published On: January 14, 2022
The Complexities of Cancer: Part 1 of 3
READ MORE
By
Maxx Chatsko
Published On: January 14, 2022
Should You Invest in Synthetic Biology Stocks?
READ MORE
By
Samantha Bailey
Published On: December 20, 2021
Can Better Antibodies Disrupt Cell Therapy?
READ MORE
By
Maxx Chatsko
Published On: November 13, 2021
I Choose Embarrassment
READ MORE
By
Dana Abramovitz
Published On: October 14, 2021
Supplement Your Approach to Health and Investing with A Dose of Patience
READ MORE
By
Maxx Chatsko
Published On: October 14, 2021
Drug Development is Risky. Let’s Count the Ways.
READ MORE
By
Dana Abramovitz
Published On: September 15, 2021
Swimming With Sharks When There’s Blood in the Water
READ MORE
By
Maxx Chatsko
Published On: September 14, 2021
Annual 2021 Review: Maxx’s 7investing Recommendations
READ MORE
By
Maxx Chatsko
Published On: August 13, 2021
What Defines a Stock Market Bubble?
READ MORE
By
Maxx Chatsko
Published On: July 15, 2021
7investing Biotech Recs: The Next De-Risking Events
READ MORE
1
2
Next
Load More Advisor Updates
Page load link
Go to Top